We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
57 hedge funds and large institutions have $23.4M invested in CTI BioPharma Corp. (DE) Common Stock in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
177% more call options, than puts
Call options by funds: $169K | Put options by funds: $61K
15% less funds holding
Funds holding: 67 → 57 (-10)
21% less capital invested
Capital invested by funds: $29.7M → $23.4M (-$6.24M)
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
58% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 19
Holders
57
Holders Change
-10
Holders Change %
-14.93%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
19
Closed
16
Calls
$169K
Puts
$61K
Net Calls
+$108K
Net Calls Change
+$121K
Top Buyers
| 1 |
Millennium Management
New York
|
+$637K |
| 2 |
Goldman Sachs
New York
|
+$350K |
| 3 |
Renaissance Technologies
New York
|
+$290K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$212K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$192K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.27M |
| 2 |
State Street
Boston,
Massachusetts
|
-$868K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$414K |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$212K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$161K |
